We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
AUM
$428M
AUM Growth
+$177M
Cap. Flow
+$173M
Cap. Flow %
40.29%
Top 10 Hldgs %
50.45%
Holding
1,542
New
464
Increased
159
Reduced
114
Closed
631

Sector Composition

Rank Sector Weight
1 Technology 17.72%
2 Financials 16.91%
3 Healthcare 13.32%
4 Industrials 7.14%
5 Consumer Discretionary 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTOO
726
DELISTED
T2 Biosystems, Inc
TTOO
0
SPLK
727
CALL
DELISTED
Splunk Inc
SPLK
$2K ﹤0.01%
20
-60
-75% -$6.65K
GBT
728
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2K ﹤0.01%
75
+28
+60% +$1.24K
AKCA
729
PUT
DELISTED
Akcea Therapeutics Inc
AKCA
$2K ﹤0.01%
+71
New +$2.15K
AVEO
730
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2K ﹤0.01%
+80
New +$2.06K
ARQL
731
CALL
DELISTED
Arqule Inc
ARQL
$2K ﹤0.01%
+435
New +$2.48K
ARQL
732
DELISTED
Arqule Inc
ARQL
$2K ﹤0.01%
500
-6,000
-92% -$34.1K
PVTL
733
CALL
DELISTED
Pivotal Software, Inc.
PVTL
$2K ﹤0.01%
+150
New +$3.66K
APC
734
CALL
DELISTED
Anadarko Petroleum
APC
$2K ﹤0.01%
+30
New +$2.02K
SGYP
735
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2K ﹤0.01%
1,500
+500
+50% +$895
NXTM
736
PUT
DELISTED
NxStage Medical Inc.
NXTM
$2K ﹤0.01%
75
-98
-57% -$2.76K
SYNT
737
CALL
DELISTED
Syntel Inc
SYNT
$2K ﹤0.01%
+54
New +$2.16K
HMNY
738
DELISTED
Helios and Matheson Analytics Inc.
HMNY
$2K ﹤0.01%
+153,004
New +$1.53M
PKO
739
DELISTED
Pimco Income Opportunity Fund
PKO
$2K ﹤0.01%
90
RHT
740
CALL
DELISTED
Red Hat Inc
RHT
$2K ﹤0.01%
+20
New +$2.86K
ALDX icon
741
PUT
Aldeyra Therapeutics
ALDX
$86.9M
$1K ﹤0.01%
+125
New +$1.01K
AMBA icon
742
CALL
Ambarella
AMBA
$3.6B
$1K ﹤0.01%
+50
New +$1.94K
ANET icon
743
PUT
Arista Networks
ANET
$257B
$1K ﹤0.01%
+96
New +$1.63K
ASM
744
Avino Silver & Gold Mines
ASM
$1.21B
$1K ﹤0.01%
+3,000
New +$3.02K
ATNM icon
745
Actinium Pharmaceuticals
ATNM
$30.2M
$1K ﹤0.01%
67
ATXS
746
DELISTED
Astria Therapeutics
ATXS
$1K ﹤0.01%
+33
New +$1.48K
BANC icon
747
Banc of California
BANC
$3.11B
$1K ﹤0.01%
+90
New +$1.77K
BLE
748
DELISTED
BlackRock Municipal Income Trust II
BLE
$1K ﹤0.01%
135
BTA
749
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
$1K ﹤0.01%
90
BWG
750
BrandywineGLOBAL Global Income Opportunities Fund
BWG
$131M
$1K ﹤0.01%
180

Similar funds

FNY Investment Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, FNY Investment Advisers held 1,542 positions worth $428M, up 70% from $251M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

FNY Investment Advisers deployed $173M of net new capital in Q3 2018, opening 464 new positions and adding to 159 existing holdings. Its largest new stake was Altra Industrial Motion Corp: 1,000,687 shares worth $41.3M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Perspecta Inc. Common Stock, an estimated $8.25M trimmed.

  • FNY Investment Advisers's largest Q3 2018 buy was Altra Industrial Motion Corp: 1,000,687 shares worth $41.3M.
  • FNY Investment Advisers added most to Aetna Inc in Q3 2018, an estimated $40.8M increase.
  • FNY Investment Advisers's biggest Q3 2018 reduction was Perspecta Inc. Common Stock, cutting an estimated $8.25M.
  • FNY Investment Advisers fully exited Keurig Dr Pepper in Q3 2018, selling an estimated $21.2M.
  • FNY Investment Advisers's ten largest holdings make up 50% of its $428M portfolio in Q3 2018.
  • FNY Investment Advisers opened 464 new positions and closed 631 in Q3 2018.
  • FNY Investment Advisers's portfolio value rose 70% quarter-over-quarter to $428M.

Based on FNY Investment Advisers's 13F filing for Q3 2018, filed 29 Oct 2018.